BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:27 PM
 | 
Feb 09, 2010
 |  BC Extra  |  Company News

FDA approves Crestor sNDA

FDA approved an sNDA from AstraZeneca plc (LSE:AZN; NYSE:AZN) for Crestor rosuvastatin to reduce the risk of stroke, myocardial infarction and arterial revascularization procedures in individuals...

Read the full 116 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >